Publicacions
-
Berrueco R, Antón A, Rives-Solà S, Català-Temprano A, Toll T, Ruiz-Llobet A, Camós-Guijosa M, Torrebadell-Burriel M, Estella J and Munoz-Almagro C.
Multiplex real-time PCR for prompt diagnosis of an outbreak of human parainfluenza 3 virus in children with acute leukemia
Infection . 41(6): 1171-1175. Nº de cites: 7
-
Pratcorona M, Brunet S, Nomdedeu J, Maria Ribera J, Tormo M, Duarte R, Escoda L, Guardia R, Queipo de Llano MP, Salamero O, Bargay J, Pedro C, Maria Marti J, Torrebadell-Burriel M, Diaz-Beya M, Camós-Guijosa M, Colomer D, Hoyos M, Sierra J, Esteve J and Grp Cooperativo Estudio.
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy
Blood . 121(14): 2734-2738. Nº de cites: 216
-
Diaz-Beya M, Navarro A, Ferrer G, Diaz T, Gel B, Camós-Guijosa M, Pratcorona M, Torrebadell-Burriel M, Rozman M, Colomer D, Monzo M and Esteve J.
Acute myeloid leukemia with translocation (8:16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene
Leukemia . 27(3): 595-603. Nº de cites: 44
-
Rives-Solà S, Estella J, Camós-Guijosa M, García-Miguel P, Verdeguer A, Couselo JM, Tasso M, Molina J, Gómez P, Fernández-Delgado R, Navajas A and Badell I.
T-cell pediatric acute lymphoblastic leukemia: analysis of survival and; prognostic factors in 4 consecutive protocols of the Spanish cooperative; study group SHOP
MEDICINA CLINICA . 139(4): 141-149. Nº de cites: 7
-
Rives-Solà S, Camós-Guijosa M, Estella J, Gómez P, López-Duarte M, Navajas A and Badell I.
Validation of the 'French Acute Lymphoblastic Leukaemia Study Group FRALLE prognostic index' for paediatric Philadelphia-chromosome acute lymphoblastic leukaemia
BRITISH JOURNAL OF HAEMATOLOGY . 156(2): 284-286. Nº de cites: 2
-
Barragán E, Montesinos P, Camós-Guijosa M, González M, Calasanz MJ, Román-Gómez J, Gómez-Casares MT, Ayala R, López J, Fuster Ó, Colomer D, Chillón C, Larrayoz MJ, Sánchez-Godoy P, González-Campos J, Manso F, Amador ML, Vellenga E, Lowenberg B, Sanz MA, PETHEMA and HOVON Groups.
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy
HAEMATOLOGICA . 96(10): 1470-1477. Nº de cites: 49
-
Maffioli M, Camós-Guijosa M, Gaya A, Hernández-Boluda JC, Alvarez-Larrán A, Domingo A, Granell M, Guillem V, Vallansot R, Costa D, Bellosillo B, Colomer D and Cervantes F.
Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
LEUKEMIA RESEARCH . 35(8): 1014-1019. Nº de cites: 45
-
Florensa L, Navarro JT, Pérez Vila ME, Domingo A, De la Banda E, Rozman M, Camós-Guijosa M, Millá F, Perea G, Alonso E, Ayats R, Aventín A, Cabezudo E, Espinet B, Merino A, Romero P, Sánchez C, Tuset E, Solé F, Feliu E, Fernández C, Gallart M, Vallespí T and Woessner S.
Persistent polyclonal B-cell lymphocytosis: study of 35 cases
MEDICINA CLINICA . 136(13): 565-573. Nº de cites: 3
-
Giné E, Martinez A, Villamor N, López-Guillermo A, Camós-Guijosa M, Martinez D, Esteve J, Calvo X, Muntañola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E and Montserrat E.
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior (Retracted Article. See vol 95, pg 1620, 2010)
HAEMATOLOGICA . 95(9): 1526-1533. Nº de cites: 130
-
Guillem VM, Cervantes F, Martínez J, Alvarez-Larrán A, Collado M, Camós-Guijosa M, Sureda A, Maffioli M, Marugán I and Hernández-Boluda JC.
XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia
AMERICAN JOURNAL OF HEMATOLOGY . 85(7): 482-486. Nº de cites: 24